INVA logo

INVA
Innoviva Inc

1,576
Mkt Cap
$1.62B
Volume
1M
52W High
$25.15
52W Low
$16.52
PE Ratio
3.65
INVA Fundamentals
Price
$21.97
Prev Close
$22.86
Open
$22.83
50D MA
$22.93
Beta
0.28
Avg. Volume
578,285.22
EPS (Annual)
$3.30
P/B
1.21
Rev/Employee
$2.67M
$1,396.70
Loading...
Loading...
News
all
press releases
Innoviva (INVA) Tops Q1 Earnings Estimates
Innoviva (INVA) delivered earnings and revenue surprises of +3.53% and -1.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
More News
News Placeholder
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
Business Wire·10d ago
News Placeholder
Pfizer (PFE) Q1 Earnings and Revenues Top Estimates
Pfizer (PFE) delivered earnings and revenue surprises of +5.63% and +4.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Jennison Associates LLC Buys New Shares in Innoviva, Inc. $INVA
Jennison Associates LLC purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 46,403 shares of the biotechnology company's stoc...
MarketBeat·13d ago
News Placeholder
Merck (MRK) Reports Q1 Loss, Tops Revenue Estimates
Merck (MRK) delivered earnings and revenue surprises of +15.47% and +2.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
Innoviva (INVA) to Release Quarterly Earnings on Wednesday
Innoviva (NASDAQ:INVA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat·18d ago
News Placeholder
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and fiv...
MarketBeat·29d ago
News Placeholder
Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average - Time to Sell?
Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
Innoviva (NASDAQ:INVA) Shares Cross Above 200 Day Moving Average - Here's What Happened
Innoviva (NASDAQ:INVA) Share Price Crosses Above 200 Day Moving Average - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Oliver Luxxe Assets LLC Makes New $1.69 Million Investment in Innoviva, Inc. $INVA
Oliver Luxxe Assets LLC acquired a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 84,671 shares of the biotechnology company's...
MarketBeat·2mo ago
<
1
2
...
>

Latest INVA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.